Compare BGLC & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGLC | SINT |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 11.7M |
| IPO Year | 2019 | 2007 |
| Metric | BGLC | SINT |
|---|---|---|
| Price | $2.28 | $2.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 8.7K | ★ 29.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,510,646.00 | $2,887,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $80.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.90 |
| 52 Week Low | $0.23 | $1.72 |
| 52 Week High | $15.19 | $6.78 |
| Indicator | BGLC | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 37.23 |
| Support Level | $1.92 | $2.55 |
| Resistance Level | $2.73 | $2.94 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 13.11 | 18.97 |
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.